Clinical Trial Update: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma [Phase 2]

View source ↗

Summary

This is a Phase 2 clinical trial update from St. Jude investigating molecular and clinical risk-directed therapy for newly diagnosed medulloblastoma in infants …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medulloblastoma

Snippet

Sponsor: St. Jude Children's Research Hospital | Conditions: Medulloblastoma | Phase 2 | Status: RECRUITING